CLL Society Introduces the Protecting Innovation in Rare Cancers
Por um escritor misterioso
Descrição
/PRNewswire/ -- CLL Society, the world
CLL Society Inc., Nonprofit organization
The Role of the Microenvironment and Immune System in Regulating
Progress in Natural Compounds/siRNA Co-delivery Employing
Women, power, and cancer: a Lancet Commission - The Lancet
Delivering Value-Based Cancer Care Across Different Populations
When dormancy fuels tumour relapse
Rational combinations of targeted cancer therapies: background
Biology, vulnerabilities and clinical applications of circulating
Computational immunogenomic approaches to predict response to
Cancer in sub-Saharan Africa: a Lancet Oncology Commission - The
Synthetic biology-inspired cell engineering in diagnosis
Innovation - CLL Society's Policy Institute - CLL Society
An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment
de
por adulto (o preço varia de acordo com o tamanho do grupo)
